Table 6.
Patients | pN + (sn) | % | p-value | |
---|---|---|---|---|
Age (years) | ||||
≤50 | 58 | 13 | 22.4 | n.s. |
>50 | 302 | 63 | 20.9 | |
BMI | ||||
<25 | 146 | 31 | 21.2 | n.s. |
25-29.9 | 125 | 26 | 20.8 | |
≥30 | 89 | 19 | 21.3 | |
Tumour stage | ||||
pT1a/b | 64 | 7 | 10.9 | 0.009 |
pT1c | 182 | 32 | 17.6 | |
pT2 | 111 | 37 | 33.3 | |
Histological subtype | ||||
Ductal | 259 | 57 | 22 | n.s. |
Lobular | 31 | 8 | 25.8 | |
Others | 70 | 11 | 15.7 | |
Grading | ||||
G1 | 63 | 5 | 7.9 | 0.014 |
G2 | 211 | 48 | 22.7 | |
G3 | 86 | 23 | 26.7 | |
Lymphangiosis | ||||
No | 250 | 21 | 8.4 | <0.001 |
Yes | 110 | 55 | 50 | |
Growth pattern | ||||
Unifocal | 335 | 65 | 19.4 | 0.021 |
Multicentric | 22 | 9 | 40.9 | |
ER status | ||||
Positive | 301 | 64 | 21.3 | n.s. |
Negative | 59 | 12 | 20.3 | |
PR status | ||||
Positive | 270 | 57 | 21.1 | n.s. |
Negative | 90 | 19 | 21.1 | |
HER2 status | ||||
Negative | 336 | 73 | 21.7 | n.s |
Positive | 24 | 3 | 12.5 | |
Ki-67 | ||||
≤14% | 142 | 24 | 16.9 | 0.067 |
>14% | 194 | 47 | 24.2 | |
Total | 360 | 76 | 21.1 |